Pfizer: Covid-19 Vaccine Effective At Preventing Symptomatic Infection In Children

• News Home
• More from International News

Friday, October 22nd, 2021 3:14pm

By Ciara Noble @niaracoble

• Share on Facebook
• Share on Messenger
• Share on Messenger
• Share on Twitter
• Share on Whatsapp

Stock image: Thirdman/Pexels

Administering reduced dosages to those aged 5-11

Pfizer says it's Covid vaccine is 91% effective at preventing symptomatic infection in children.

The study examined administering the vaccine to children aged 5-11, in reduced dosages.

In the US, regulators are expected to decide on the approval of the vaccine for children, from the age of 5.

While, the European Medicines Agency is due to make a judgement on its usage in children, in the coming months.

More from International News

• First Omicron Cases in Australia

  Two Omicron Cases in Sydney

• Belgium Becomes First EU State To Confirm Case of New Covid-19 Variant

  EC recommends cancellation of flights from Southern African countries

• Women’s Aid Calls for Zero Tolerance of Intimate Relationship Abuse among Young People

  The UN Day Opposing Violence against Women is Thursday 25 November 2021.

• Decision On Covid-19 Vaccinations For Children Aged 5-11 To Be Delivered By EMA Tomorrow

  Pfizer Bio-N-Tech vaccine

• Germany Quarantines Irish Non-Vaccinated

  Many European countries have started to reimpose restrictions in light of the latest wave.

• Funeral Of Murdered MP Takes Place

  David Amess stabbed to death during constituency surgery

• New obesity drug cuts body weight by 11% by making people feel less hungry

  Doctors have said the drug is a medical breakthrough.

• Lockdown Protests Turn Violent In Rotterdam

  Several people injured during demonstrations